EUVIMEDEUVIMED entdecken
Crossref

PSMA Total Tumor Volume: A Simple Quantifiable Biomarker for Overall Survival Prediction—Results from the International PROMISE PET Registry

Madeleine J Karpinski, Caner Civan, Sebastian Hoberück, Osman Güven, Weijun Wei, Matteo Bauckneht, Glenn Bauman, Anders Bjartell, Alexis Vrachimis, Dominic Ufton, Ali Kibar, Mohd Fazrin Mohd Rohani und 35 weitere

Journal of Nuclear Medicine · 12.11.2026 · jnumed.126.273371

DOI: 10.2967/jnumed.126.273371 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Nuclear Medicine, online erschienen am 12.11.2026. Verfasst von Madeleine J Karpinski und 46 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine and West German Cancer Center, University Hospital Essen, Essen, Germany; madeleine.karpinski@uk-essen.de. Die Arbeit nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prostate-specific membrane antigen (PSMA) PET is an accurate prognostic imaging biomarker of survival in patients with prostate cancer when assessed using Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE) criteria. Previously, PSMA PET PROMISE risk nomograms were created that surpassed clinical prediction tools. In this study, we focused on the evaluation of quantifiable biomarkers to simplify and facilitate overall survival (OS) prediction.

Methods

Data from patients with histologically proven prostate cancer who underwent PSMA PET between December 2012 and April 2024 at participating imaging centers worldwide and who were included in the PROMISE PET Registry by January 31, 2026, were analyzed. Prostate-specific antigen (PSA) levels at PSMA PET, disease stage, and OS follow-up data were collected. PSMA total tumor volume (PSMA TTV) and whole-body SUVmean were assessed using predefined SUV thresholds. PSMA total lesion uptake (PSMA TL) was calculated as PSMA TTV × SUVmean PSA level at PSMA PET adjusted for PSMA TTV was calculated as PSA × TTV. Univariate regression analysis was conducted to identify potential predictors. Prognostic accuracy of quantitative biomarkers was compared using Harrell C-indices and time-dependent concordance in the development cohort. Probabilities for 3-, 5-, and 7-y OS across PSMA TTV quartiles were derived from Kaplan-Meier curves. Subgroup analysis was conducted by cancer stage.

Results

In total, 13,893 patients were included in the analysis and divided 2:1 into development (n = 9271) and validation (n = 4622) cohorts. The prognostic accuracy of PSMA TTV in the validation cohort (C-index, 0.78; 95% CI, 0.77-0.80) was superior to SUVmean (C-index, 0.62; 95% CI, 0.61-0.64) and PSA level at PET (C-index, 0.71; 95% CI, 0.69-0.72) and similar to PSMA TL (C-index, 0.78; 95% CI, 0.76-0.79) and PSA × TTV (C-index, 0.77; 95% CI, 0.75-0.78). In the entire cohort, the median OS for PSMA TTV quartile 1 (0 mL) and quartile 2 (>0-2.1 mL) was not reached. The median OS was 11.4 y (interquartile range, 10.1 y to not reached) for PSMA TTV quartile 3 (>2.1-16.2 mL) and 4.4 y (interquartile range, 4.2-4.6 y) for quartile 4 (>16.17 mL).

Conclusion

Among quantifiable PET metrics, PSMA TTV had the highest prognostic accuracy for OS in patients with prostate cancer. Automated PSMA TTV assessment may facilitate fast and reproducible outcome prediction in the future.

Schlagwörter

Stichwörter der Autor:innen

PROMISE RegistryPSMA PETPSMA TTVoverall survivalquantitative biomarker

Autor:innen und Institutionen

  • Department of Nuclear Medicine and West German Cancer Center, University Hospital Essen, Essen, Germany; madeleine.karpinski@uk-essen.de.
  • Department of Nuclear Medicine and West German Cancer Center, University Hospital Muenster, Muenster, Germany.
  • Department of Nuclear Medicine, University Hospital of Cologne, Cologne, Germany.
  • Department of Nuclear Medicine and West German Cancer Center, University Hospital Essen, Essen, Germany.
  • Department of Nuclear Medicine, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.
  • Department of Nuclear Medicine, University Hospital Technical University Munich, Munich, Germany.

Zitieren

APA

Karpinski, M. J., Civan, C., Hoberück, S., Güven, O., Wei, W., Bauckneht, M., Bauman, G., Bjartell, A., Vrachimis, A., Ufton, D., Kibar, A., Mohd Rohani, M. F., Evangelista, L., Beintner-Skawran, S. M., Soeterik, T. F. W., Sanli, Y., Maman, A., Tao, W., Zacho, H. D., …, & PROMISE Registry Group (2026). PSMA Total Tumor Volume: A Simple Quantifiable Biomarker for Overall Survival Prediction—Results from the International PROMISE PET Registry. Journal of Nuclear Medicine, jnumed.126.273371. https://doi.org/10.2967/jnumed.126.273371

Vancouver

Karpinski MJ, Civan C, Hoberück S, Güven O, Wei W, Bauckneht M, et al. PSMA Total Tumor Volume: A Simple Quantifiable Biomarker for Overall Survival Prediction—Results from the International PROMISE PET Registry. Journal of Nuclear Medicine. 2026:jnumed.126.273371. doi:10.2967/jnumed.126.273371

BibTeX
@article{Karpinski2026,
  author = {Karpinski, Madeleine J and Civan, Caner and Hoberück, Sebastian and Güven, Osman and Wei, Weijun and Bauckneht, Matteo and Bauman, Glenn and Bjartell, Anders and Vrachimis, Alexis and Ufton, Dominic and Kibar, Ali and Mohd Rohani, Mohd Fazrin and Evangelista, Laura and Beintner-Skawran, Stephan M and Soeterik, Timo F W and Sanli, Yasemin and Maman, Adem and Tao, Weijing and Zacho, Helle D and Goffin, Karolien and Hofman, Michael S and Runkel, Lucia and Selvamoorthy, Thanusiah and Alcin, Göksel and Herrmann, Ken and Kesch, Claudia and Umutlu, Lale and Hope, Thomas and Gafita, Andrei and Miksch, Jonathan and Kind, Felix and Pizzuto, Daniele Antonio and İnce, Burak and Arslan, Esra and Emmett, Louise and Kunikowska, Jolanta and Vondrak, Andrej and Güzel, Yunus and Di Giorgio, Andrea and Holzgreve, Adrien and Pfob, Christian H and Calais, Jeremie and Koehler, Daniel and Rahbar, Kambiz and Hadaschik, Boris and Fendler, Wolfgang P and PROMISE Registry Group, PROMISE Registry Group},
  title = {PSMA Total Tumor Volume: A Simple Quantifiable Biomarker for Overall Survival Prediction—Results from the International PROMISE PET Registry},
  journal = {Journal of Nuclear Medicine},
  year = {2026},
  pages = {jnumed.126.273371},
  doi = {10.2967/jnumed.126.273371}
}
Kostenlos starten →